Ryan Daniels' Stock Ratings

William Blair Analyst

Ryan Daniels is an analyst at William Blair. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024

Overall Average Return

-44.7%

Smart Score

21.7%

Overall Average Return Percentile

4th

Number of Ratings

6
Buy NowGet Alert
07/02/2024WAYBuy Now
Waystar Holding
$21.22——Initiates → OutperformGet Alert
08/07/2023TRHCBuy Now
Tabula Rasa HealthCare
———DowngradeOutperform → Market PerformGet Alert
04/19/2023DHBuy Now
Definitive Healthcare
$5.36——Initiates → OutperformGet Alert
09/21/2022AMEHBuy Now
Apollo Medical Hlgs
———Initiates → OutperformGet Alert
04/28/2022TDOCBuy Now
Teladoc Health
$9.28——DowngradeOutperform → Market PerformGet Alert
01/04/2022PIIIBuy Now
P3 Health Partners
$0.50——Initiates → OutperformGet Alert

Recent Analyst Stock Rating News

Analysts Rally Behind Waystar: Predict Robust Growth and Market Share Gains Following Competitor Setback
Waystar Holding Corp. garners bullish analyst coverage on growth prospects fueled by market demand, competitive advantages, and post-cyberattack opportunities.
Nasdaq, S&P 500 Futures Surge As Earnings Optimism Drives Positive Sentiment: Analyst Lists 3 Factors For Higher Market Multiples
U.S. stocks are set for additional gains on Monday, building on the momentum of the S&P 500 reaching a new high last Friday, with earnings expected to be the focal point throughout the upcoming week.
Why Health Management Company P3 Health Partners Shares Are Up Today
P3 Health Partners Inc (NASDAQ: PIII) shares are trading higher by around 10% after the company reaffirmed guidance for 2023 and 
Why Healthcare Technology Company Accolade Shares Are Surging Today
Accolade Inc (NASDAQ: ACCD) shares are trading higher after the company announced 
Why Are Tabula Rasa HealthCare Shares Moving Higher Today?
Nautic Partners agreed to acquire Tabula Rasa HealthCare Inc (NASDAQ: TRHC) for $10.50 in cash per share and combine with ExactCare Pharmacy, a portfolio company of Nautic. 
IDEXX Laboratories' Q2 Earnings Top Estimates, Analyst Maintain Outperform Citing Resilient Animal Health Market
IDEXX Laboratories Inc (NASDAQ: IDXX) reported Q2 FY23 sales of $943.63 million, beating the consensus of $927.84 million
Teladoc Financials Impress in Q2: Analysts Optimistic On Q2 Performance But Stay On Sidelines
Teladoc Health Inc (NYSE: TDOC) shares are trading higher after the company reported better-than-expected 
HealthStream Posts Better-Than-Expected Q2 Earnings As Value Proposition Remains Strong: Analyst
HealthStream Inc (NASDAQ: HSTM) posted second-quarter (Q2) EPS of $0.13, up 30% year-over-year, beating the 
Trump Hearing In NYC Inspires Bomb Threat After Lindsey Graham Calls Possible Indictment 'B.S. That Will Blow Up Country'
New York City law enforcement is on high alert due to two separate legal cases involving former President Donald Trump.
Trump's Looming Indictment, The Potential Outcomes And How Fox Could Handle Following Tucker Carlson Revelations
In an unprecedented turn of events, former President Donald Trump could find himself indicted on criminal charges in relation to the payment of hush money to porn star Stormy Daniels, according to a report.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free